Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Oncology|January 25, 2023
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient diseaseMohamed E Elsesy, Su Jung Oh-Hohenhorst, Christoph Oing, et al.
Cancers|September 4, 2020
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break RepairMohamed E Elsesy, Su Jung Oh-Hohenhorst, Anastassia Löser, et al.
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.
BMC Cancer|July 28, 2017
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancerFrank Jacobsen, Billurvan Taskin, Nathaniel Melling, et al.
British Journal of Cancer|July 7, 2026
Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR statusMohamed E Elsesy, Ayham Moustafa, Su-Jung Oh-Hohenhorst, et al.
Molecular Cancer Research : MCR|January 14, 2018
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor ModelDaniel Benten, Yasmin Behrang, Ludmilla Unrau, et al.
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
The Journal of Clinical Investigation|February 3, 2026
Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitizationSabrina Köcher, Mohamed E Elsesy, Ayham Moustafa, et al.
Pageof 3